To establish whether insulin resistance and/or postprandial fatty acid metabolism might
contribute to familial combined hyperlipidemia (FCH) we have examined parameters of …

Familial combined hyperlipidemia (FCHL) is one of the most common familial dyslipidemias
associated with premature heart disease. Subjects with FCHL typically have elevated …

Familial dyslipidemic hypertension (FDH) is a syndrome recently described from sibships
selected for early familial hypertension and found to have one or more of three fasting lipid …

The pathophysiology of familial combined hyperlipidemia (FCHL) is unknown, but altered
lipid turnover in peripheral tissues as well as hepatic overproduction of apolipoprotein B …

Familial combined hyperlipidemia (FCHL) is a common cause of premature myocardial
infarction, but its metabolic basis is unknown. Insulin resistance has been suggested in …

Very low density lipoprotein kinetic parameters were compared in familial
hypertriglyceridaemia and familial combined hyperlipidaemia, two distinct genetic forms of …

Hepatic VLDL overproduction in familial combined hyperlipidaemia (FCH) may delay the
clearance of atherogenic apolipoprotein (apo) B containing particles. We investigated if …

Familial combined hyperlipidemia (FCHL) was originally described as a disorder
characterized by elevated levels of either plasma cholesterol or triglyceride (TG) or both in …

In order to characterize the lipoprotein abnormalities in familial combined hyperlipidemia
(FCHL) and to describe factors associated with the stability of the FCHL phenotype during …

Plasma lipoprotein concentration, composition, and size were evaluated in two common
familial forms of hypertriglyceridemia and compared with those in normal subjects. The very …